Literature DB >> 15940292

Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD.

L Kent1, E Green, Z Hawi, A Kirley, F Dudbridge, N Lowe, R Raybould, K Langley, N Bray, M Fitzgerald, M J Owen, M C O'Donovan, M Gill, A Thapar, N Craddock.   

Abstract

Attention deficit hyperactivity disorder (ADHD) is a common, highly heritable, neurodevelopmental disorder with onset in early childhood. Genes involved in neuronal development and growth are, thus, important etiological candidates and brain-derived neurotrophic factor (BDNF), has been hypothesized to play a role in the pathogenesis of ADHD. BDNF is a member of the neurotrophin family and is involved in the survival and differentiation of dopaminergic neurons in the developing brain (of relevance because drugs that block the dopamine transporter can be effective therapeutically). The common Val66Met functional polymorphism in the human BDNF gene (rs 6265) was genotyped in a collaborative family-based sample of 341 white UK or Irish ADHD probands and their parents. We found evidence for preferential transmission of the valine (G) allele of BDNF (odds ratio, OR=1.6, P=0.02) with a strong paternal effect (paternal transmissions: OR=3.2, P=0.0005; maternal transmissions: OR=1.00; P=1.00). Our findings support the hypothesis that BDNF is involved in the pathogenesis of ADHD. The transmission difference between parents raises the possibility that an epigenetic process may be involved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15940292     DOI: 10.1038/sj.mp.4001696

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  35 in total

1.  Attention deficit/hyperactivity disorder symptoms and depression symptoms as mediators in the intergenerational transmission of smoking.

Authors:  Alex Zoloto; Craig T Nagoshi; Clark Presson; Laurie Chassin
Journal:  Drug Alcohol Depend       Date:  2012-06-08       Impact factor: 4.492

2.  Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest-posttest study.

Authors:  Aynur Pekcanlar Akay; Halil Resmi; Sevay Alsen Güney; Handan Özek Erkuran; Gonca Özyurt; Enis Sargin; Ahmet Topuzoglu; Ali Evren Tufan
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-07-14       Impact factor: 4.785

Review 3.  Ten good reasons to consider biological processes in prevention and intervention research.

Authors:  Theodore P Beauchaine; Emily Neuhaus; Sharon L Brenner; Lisa Gatzke-Kopp
Journal:  Dev Psychopathol       Date:  2008

4.  Changes in the serum levels of brain-derived neurotrophic factor in adults with attention deficit hyperactivity disorder after treatment with atomoxetine.

Authors:  Josep Antoni Ramos-Quiroga; Margarida Corominas-Roso; Gloria Palomar; Nuria Gomez-Barros; Marta Ribases; Cristina Sanchez-Mora; Rosa Bosch; Mariana Nogueira; Montserrat Corrales; Sergi Valero; Miguel Casas
Journal:  Psychopharmacology (Berl)       Date:  2013-11-08       Impact factor: 4.530

5.  Differential Behavioral and Biochemical Responses to Caffeine in Male and Female Rats from a Validated Model of Attention Deficit and Hyperactivity Disorder.

Authors:  Fernanda Nunes; Daniela Pochmann; Amanda Staldoni Almeida; Daniela Melo Marques; Lisiane de Oliveira Porciúncula
Journal:  Mol Neurobiol       Date:  2018-03-20       Impact factor: 5.590

6.  Sleep disturbances in prepubertal children with attention deficit hyperactivity disorder: a home polysomnography study.

Authors:  Reut Gruber; Tong Xi; Sonia Frenette; Manon Robert; Phetsamone Vannasinh; Julie Carrier
Journal:  Sleep       Date:  2009-03       Impact factor: 5.849

Review 7.  Genetic aspects in attention-deficit/hyperactivity disorder.

Authors:  O Albayrak; S Friedel; B G Schimmelmann; A Hinney; J Hebebrand
Journal:  J Neural Transm (Vienna)       Date:  2008-01-16       Impact factor: 3.575

8.  Rare DNA variants in the brain-derived neurotrophic factor gene increase risk for attention-deficit hyperactivity disorder: a next-generation sequencing study.

Authors:  Z Hawi; T D R Cummins; J Tong; M Arcos-Burgos; Q Zhao; N Matthews; D P Newman; B Johnson; A Vance; H S Heussler; F Levy; S Easteal; N R Wray; E Kenny; D Morris; L Kent; M Gill; M A Bellgrove
Journal:  Mol Psychiatry       Date:  2016-07-26       Impact factor: 15.992

9.  Association study between BDNF gene polymorphisms and autism by three-dimensional gel-based microarray.

Authors:  Lu Cheng; Qinyu Ge; Pengfeng Xiao; Beili Sun; Xiaoyan Ke; Yunfei Bai; Zuhong Lu
Journal:  Int J Mol Sci       Date:  2009-06-02       Impact factor: 6.208

10.  Effects of maternal and paternal smoking on attentional control in children with and without ADHD.

Authors:  Marieke E Altink; Dorine I E Slaats-Willemse; Nanda N J Rommelse; Cathelijne J M Buschgens; Ellen A Fliers; Alejandro Arias-Vásquez; Xiaohui Xu; Barbara Franke; Joseph A Sergeant; Stephen V Faraone; Jan K Buitelaar
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-03-14       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.